Selective tumor cell killing by triptolide in p53 wild-type and p53 mutant ovarian carcinomas. | Profiles RNS

RCMI Coordinating Center (RCMI CC)

Selective tumor cell killing by triptolide in p53 wild-type and p53 mutant ovarian carcinomas.

Wu J, Li QQ, Zhou H, Lu Y, Li JM, Ma Y, Wang L, Fu T, Gong X, Weintraub M, Wu S, Ding H. Selective tumor cell killing by triptolide in p53 wild-type and p53 mutant ovarian carcinomas. Med Oncol. 2014 Jul; 31(7):14.

View in: PubMed

authors with profiles

Qing Li, PhD

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support